|
Lucas-Ruiz F, Vidal-Correoso D, Mateo SV, de la Torre-Alamo MM, Jover-Aguilar M, Alconchel F, Martinez-Alarcon L, Lopez-Lopez V, Rios-Zambudio A, Cascales P, Pelegrin P, Pons JA, Ramirez P, Baroja-Mazo A. Intrahepatic donor microbiota-based metataxonomic signature detected in organ preservation solution enables prediction of short-term liver transplant outcomes. Gut. 2025 Aug 12:gutjnl-2025-335986. doi: 10.1136/gutjnl-2025-335986. Online ahead of print. PubMed PMID: 40803752.
AÑO: 2025; IF: 25.8
|
|
Lopez-Hernandez R, de la Torre-Alamo MM, Garcia-Bueno B, Baroja-Mazo A, Fenoy FJ, Cuevas S. Inflammasomes in Alzheimer's Progression: Nrf2 as a Preventive Target. Antioxidants (Basel). 2025 Jan 21;14(2):121. doi: 10.3390/antiox14020121. PubMed PMID: 40002308; PubMed Central PMCID: PMC11851705.
AÑO: 2025; IF: 6.6
|
|
Alarcon-Vila C, Hurtado-Navarro L, Mateo SV, Penin-Franch A, Martinez CM, Molina-Lopez C, Banos MC, Gomez AI, Gomez-Roman J, Baroja-Mazo A, Arostegui JI, Palmou-Fontana N, Martinez-Garcia JJ, Pelegrin P. The inflammasome adaptor protein ASC promotes amyloid deposition in cryopyrin-associated periodic syndromes. EMBO Mol Med. 2025 Jan;17(1):41-53. doi: 10.1038/s44321-024-00176-1. Epub 2024 Dec 5. PubMed PMID: 39639164; PubMed Central PMCID: PMC11731034.
AÑO: 2025; IF: 8.3
|
|
López-Hernández R., de la Torre-Álamo M.M., García-Bueno B., Baroja-Mazo A., Fenoy F.J., Cuevas S. Inflammasomes in Alzheimer’s Progression: Nrf2 as a Preventive Target. Antioxidants. February 2025. 14. 10.3390/antiox14020121
AÑO: 2025; IF: 6.6
|
|
Esteban-Gil A, Martinez-Garcia JJ, Vidal-Correoso D, Munoz-Morales AM, Ramirez P, Pons JA, Baroja-Mazo A. Operational tolerance research in liver transplantation: a bibliometric analysis using a new web resource. Front Res Metr Anal. 2024 Mar 14;9:1368534. doi: 10.3389/frma.2024.1368534. eCollection 2024. PubMed PMID: 38550796; PubMed Central PMCID: PMC10973155.
AÑO: 2024; IF: 1.6
|